Beijing Youngen Biotechnology Co., Ltd.
Beijing Youngen Biotechnology Co., Ltd.

MULTI-GENES AND MULTI-ORGANS TARGETING PLATFORM



The Multi-genes siRNA platform connects two different siRNAs via alinker, enabling thesimultaneous inhibition of two distinct genes in asingle target organ. This allows for theconcurrent treatment of twodiseases or the intervention of two targets for a single disease.significantly improving patient compliance

MULTI-GENES_220×109(1).png

The Multi-organs siRNA platform conjuates siRNAs with different ligands. breaking through the limitation of existing siRNA technologies that only enable delivery to a single target tissue. lt achieves targeted inhibition of the same target gene acros different target tissues and organs, featuring high precision, controllability, efficiency and durability.


What's New at Youngen